Login to Your Account



Other News To Note


Wednesday, August 22, 2012
• NPS Pharmaceuticals Inc., of Bedminster, N.J., said it was notified by the FDA that its new drug application for Gattex (teduglutide) will be discussed at the meeting of the Gastrointestinal Drugs Advisory Committee on Oct. 16.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription